Thursday, November 06, 2025

Fake or the real thing? How AI can make it harder to trust the pictures we see


New study reveals we can't always spot a fake image - even when we are familiar with the subject in the photo




Swansea University




A new study has revealed that artificial intelligence can now generate images of real people that are virtually impossible to tell apart from genuine photographs.

Using AI models ChatGPT and DALL·E, a team of researchers from Swansea University, the University of Lincoln and Ariel University in Israel, created highly realistic images of both fictional and famous faces, including celebrities.

They found that participants were unable to reliably distinguish them from authentic photos—even when they were familiar with the person’s appearance.

Across four separate experiments the researchers noted that adding comparison photos or the participants’ prior familiarity with the faces provided only limited help.

The research has just been published by journal Cognitive Research: Principles and Implications and the team say their findings highlight a new level of “deepfake realism,” showing that AI can now produce convincing fake images of real people which could erode trust in visual media.

Professor Jeremy Tree, from the School of Psychology, said: “Studies have shown that face images of fictional people generated using AI are indistinguishable from real photographs. But for this research we went further by generating synthetic images of real people.

“The fact that everyday AI tools can do this not only raises urgent concerns about misinformation and trust in visual media but also the need for reliable detection methods as a matter of urgency.”

One of the experiments, which involved participants from US, Canada, the UK, Australia and New Zealand, saw subjects shown a series of facial images, both real and artificially generated, and they were asked to identify which was which. The team say the fact the participants mistook the AI-generated novel faces for real photos indicated just how plausible they were.

Another experiment saw participants asked to if they could tell genuine pictures of Hollywood stars such as Paul Rudd and Olivia Wilde from computer-generated versions. Again the study’s results showed just how difficult individuals can find it to spot the authentic version.

The researchers say AI’s ability to produce novel/synthetic images of real people opens up a number of avenues for use and abuse. For instance, creators might generate images of a celebrity endorsing a certain product or political stance, which could influence public opinion of both the identity and the brand/organisation they are portrayed as supporting.

Professor Tree added: “This study shows that AI can create synthetic images of both new and known faces that most people can’t tell apart from real photos. Familiarity with a face or having reference images didn’t help much in spotting the fakes, that is why we urgently need to find new ways to detect them.

“While automated systems may eventually outperform humans at this task, for now, it’s up to viewers to judge what’s real.”

 

Archaeology: Digital map increases Roman Empire road network by 100,000 kilometers



Springer Nature





A new high resolution digital dataset and map — named Itiner-e — of roads throughout the Roman Empire around the year 150 CE is presented in research published in Scientific Data. The findings increase the known length of the Empire’s road system by over 100,000 kilometres.

At its height in the second century CE, the Roman Empire included over 55 million people and stretched from modern day Britain to Egypt and Syria. Although a network of roads throughout the Empire facilitated its development and maintenance, it remains incompletely mapped and existing digitisations are low resolution.

Tom Brughmans, Pau de Soto and Adam Pažout and colleagues created Itiner-e using archaeological and historical records, topographic maps, and satellite imagery. The dataset includes 299,171 kilometres of roads — an increase from a previous estimate of 188,555 kilometres — covering almost four million square kilometres. The authors attribute this increase in road coverage to higher coverage of roads in the Iberian Peninsula, Greece and North Africa and to the adapting of previously proposed road routes to fit geographical realities. This includes allowing roads crossing mountains to follow winding paths rather than direct lines. Itiner-e comprises 14,769 road sections, with 103,478 kilometres (34.6%) classified as main roads and 195,693 kilometres (65.4%) as secondary roads. The authors report that the precise locations of only 2.7% of the roads are known with certainty, while 89.8% are less precisely known, and 7.4% are hypothesised.

The authors suggest that Itiner-e represents the most detailed and comprehensive openly accessible digitisation of the Empire’s roads and that it also highlights gaps in current knowledge of the road system. They note that Itiner-e cannot show changes in the road system over time and that future research is needed to investigate this throughout the Empire. They propose that Itiner-e could be used in future research investigating the influence of Roman roads on connectivity, administration, migration, and disease transmission in the Empire.

 

Informal human milk sharing among US mothers



JAMA Network Open





About The Study: 

In this large, diverse sample of first-time mothers in the U.S., 1 in 27 participants reported feeding their infants shared human milk. Prior work indicates that families engage in many, but not all, recommended milk sharing risk mitigation measures and fear disclosing their milk sharing to practitioners. Given the prevalence in this study, pediatric practitioners should be aware that milk sharing occurs across demographics; they can counsel families considering or using shared milk on risks and risk-reduction strategies recommended by the Academy of Breastfeeding Medicine and the American Academy of Nursing, while noting that evidence on home pasteurization is still evolving. 


Corresponding Author: To contact the corresponding author, Jill R. Demirci, PhD, email jvr5@pitt.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.42036)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article 

 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.42036?guestAccessKey=1b34668e-afe8-4888-aa3d-dd05b3b83eff&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110625

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

UBC study shows good B.C. abortion pill access, but gaps remain




University of British Columbia




Most pharmacies in British Columbia can provide the abortion pill mifepristone within days, but uneven access still leaves some women facing barriers to this time-sensitive medication, according to new research. 

The study, published Nov. 6 in JAMA Network Open, offers the first province-wide look at pharmacy-level access to mifepristone in B.C. 

Mifepristone is used for medical abortions and can be prescribed across Canada by any physician or nurse practitioner and filled at community pharmacies. Initially available only from pharmacists who had completed a training module and pharmacies registered with the manufacturer, Health Canada removed these requirements in 2017 to improve access to abortion care. The new study shows that, while access has improved dramatically, gaps remain.  

“In abortion care, every day matters,” says lead author Dr. Elizabeth Nethery, postdoctoral research fellow at UBC's faculty of pharmaceutical sciences. “The medication is approved for use up to the ninth week of pregnancy, but people usually become aware they’re pregnant at around six to seven weeks, so timely access is important to maintain and respect a person’s choice to have an abortion.” 

In addition, maintaining access to medical abortion is important because people can access this from primary care or through telehealth in B.C. without travelling outside of their community.  

Access is strong overall—but not universal

The UBC-led team conducted a "mystery shopper" survey in summer 2024, phoning more than 1,400 pharmacies across B.C. while posing as patients seeking mifepristone. Two-thirds, or 67 per cent, could fill the prescription within three days—a timeframe considered acceptable for timely care. 

Geography played an unexpected role: rural pharmacies performed slightly better than urban ones. The researchers theorized that in smaller communities, pharmacists often know who stocks which medications and coordinate informally.  

In cities, where pharmacies are more numerous but potentially less connected, callers were more likely to be told simply to "try somewhere else." 

The study found no clear link between access and pharmacy chain affiliation. Independent, franchise and large-brand pharmacies performed similarly, suggesting that corporate structure doesn't predict availability. 

When the system stalls

Among pharmacies unable to supply the medication within three days, only one in three offered a valid referral, meaning they directed callers to another pharmacy that could supply within the acceptable care period. Researchers say weak referral practices create unnecessary stress and inequities, especially for people in marginalized or lower-income communities. 

“In Vancouver, for example, a patient might need to call five or six pharmacies before finding one with mifepristone available, losing precious time and adding more stress for something that should be straightforward,” says senior author Dr. Laura Schummers, assistant professor at UBC's faculty of pharmaceutical sciences.  

Closing the gaps 

The researchers say better communication between pharmacies, clearer referral systems and refresher training could close the remaining gaps. 

"In many ways, what we found is a success story. When mifepristone is treated like a routine prescription, B.C. pharmacies are, for the most part, supporting local access to this important health care service," says Dr. Schummers. 

Interview languages: English